Document Detail


Insulin/Insulin-like growth factor signaling controls non-Dauer developmental speed in the nematode Caenorhabditis elegans.
MedLine Citation:
PMID:  20944013     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Identified as a major pathway controlling entry in the facultative dauer diapause stage, the DAF-2/Insulin receptor (InsR) signaling acts in multiple developmental and physiological regulation events in Caenorhabditis elegans. Here we identified a role of the insulin-like pathway in controlling developmental speed during the C. elegans second larval stage. This role relies on the canonical DAF-16/FOXO-dependent branch of the insulin-like signaling and is largely independent of dauer formation. Our studies provide further evidence for broad conservation of insulin/insulin-like growth factor (IGF) functions in developmental speed control.
Authors:
Anne-Françoise Ruaud; Iskra Katic; Jean-Louis Bessereau
Related Documents :
10712383 - Enhanced expression of osteopontin in human diabetic artery and analysis of its functio...
8382493 - Insulin stimulates the degradation of irs-1 in 3t3-l1 adipocytes.
1102313 - Behaviour of the duct-ligated canine pancreas during hypothermic albumin perfusion.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-10-13
Journal Detail:
Title:  Genetics     Volume:  187     ISSN:  1943-2631     ISO Abbreviation:  Genetics     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2011-01-12     Completed Date:  2011-04-20     Revised Date:  2011-08-01    
Medline Journal Info:
Nlm Unique ID:  0374636     Medline TA:  Genetics     Country:  United States    
Other Details:
Languages:  eng     Pagination:  337-43     Citation Subset:  IM    
Affiliation:
Ecole Normale Supérieure, Biology of the Ecole Normale Supérieure, F-75005 Paris, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Alleles
Animals
Caenorhabditis elegans / cytology*,  drug effects,  growth & development*,  metabolism
Caenorhabditis elegans Proteins / genetics,  metabolism*
Dimethylphenylpiperazinium Iodide / pharmacology
Insulin / metabolism*
Larva / drug effects,  growth & development,  metabolism
Receptor, Insulin / genetics,  metabolism
Signal Transduction* / drug effects
Somatomedins / metabolism*
Time Factors
Transcription Factors / metabolism
Chemical
Reg. No./Substance:
0/Caenorhabditis elegans Proteins; 0/DAF-2 protein, C elegans; 0/Somatomedins; 0/Transcription Factors; 0/daf-16 protein, C elegans; 11061-68-0/Insulin; 54-77-3/Dimethylphenylpiperazinium Iodide; EC 2.7.10.1/Receptor, Insulin
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Functional redundancy of paralogs of an anaphase promoting complex/cyclosome subunit in Caenorhabdit...
Next Document:  Mutual antagonism between the anaphase promoting complex and the spindle assembly checkpoint contrib...